Press Releases

Physicians are highly engaged with social media for both personal and professional use, according to a 4,033-clinician study authored and conducted by QuantiaMD, the largest mobile and online physician community, and Care Continuum Alliance, an international association for...

The federal government today issued a contract for advanced research and development of a dual-purpose broad spectrum antibiotic with potential to treat illnesses caused by bioterrorism threats such as plague and tularemia, as well as more certain life-threatening...

Hybrigenics, a bio-pharmaceutical company listed on Alternext (NYSE-Euronext) in Paris, with a focus on research and development of new treatments of proliferative diseases, announces today that AFSSAPS, the French drug agency, has granted authorization for a Phase II clinical...

Synta Pharmaceuticals Corp. (NASDAQ:SNTA) today announced that the Company will be presenting at the Rodman & Renshaw Annual Global Investment Conference on Tuesday, September 13 at 11:15 a.m. (ET) in New York. About Synta...

Cytocell announced today the launch of its latest FISH probe to aid in determining the prognosis of patients with chronic lymphocytic leukemia (CLL), a cancer of the lymphocytes. Cytocell’s Aquarius® P53/ATM Probe Combination detects cytogenetic abnormalities in bone marrow...

A pilot program at Mayo Clinic using telemedicine technology is showing promise for patients with concussions in rural Arizona. Doctors at Mayo Clinic in Phoenix recently conducted a live audio-video evaluation of a 15-year-old soccer player in Show...

STERIS, a global leader in decontamination and infection control, has recently announced major new investment in its Albert Browne Ltd subsidiary, helping to ensure the future development of this world class and globally trusted brand of sterilisation monitoring...